BlackBerry Ltd (NASDAQ:BBRY) announced that BlackBerry 10 mobility solution is the first to receive Full Operational Capability (FOC) on U.S. Department of Defense Networks. This comes after BlackBerry Ltd (NASDAQ:BBRY) achieved Authority To Operate certification back in August 2013. BlackBerry Ltd (NASDAQ:BBRY) shares after opening at $9.14 moved to $9.21 on last trade day and at the end of the day closed at $9.05. Company price to sales ratio in past twelve months was calculated as 0.38 and price to cash ratio as 1.74. BlackBerry Ltd (NASDAQ:BBRY) showed a negative weekly performance of -3.93%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares gained 4.21% to $7.92. The company on Mar. 24 announced the initiation of a pivotal global Phase 2 trial of AP26113 in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated with crizotinib. Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) shares fell 0.91% in last trading session and ended the day on $7.60. Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA)return on equity ratio is recorded as -98.50% and its return on assets is -65.80% Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) yearly performance is -58.49%.
Celgene Corporation (NASDAQ:CELG)’s shares declined 3.74% to $144.420. The company on Mar. 23 released new research findings on OTEZLA®(apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), from the ESTEEM 1 and 2 phase III studies in patients with moderate to severe plaque psoriasis at the 72nd Annual Meeting of the American Academy of Dermatology (AAD) Annual Meeting in Denver, CO. Celgene Corporation (NASDAQ:CELG) shares moved down -0.27% in last trading session and was closed at $142.22, while trading in range of $ 139.70 – 143.68. Celgene Corporation (NASDAQ:CELG) year to date (YTD) performance is -15.83%.
Red Hat (NYSE:RHT) is scheduled to issue its Q414 quarterly earnings data on Thursday, March 27th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $398.84 million for the quarter. Red Hat Inc (NYSE:RHT) weekly performance is -4.00%. On last trading day company shares ended up $56.13. Red Hat Inc (NYSE:RHT) distance from 50-day simple moving average (SMA50) is -3.32. %. Analysts mean target price for the company is $62.13.